← Back
Data updated: Mar 10, 2026
SCPHARMACEUTICALS
Cardiovascular
SCPHARMACEUTICALS is a pharmaceutical company focused on Cardiovascular. Key products include FUROSCIX.
2022
Since
1
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs Phase 3: 2 Phase 2: 3 Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-10-07
- Latest
- 2025-12-22
- Applications
- 1